- Home
- MRNA vs WAL Comparison
MRNA vs WAL Comparison
Compare MRNA & WAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- WAL
- Stock Information
- Founded
- MRNA 2010
- WAL 1994
- Country
- MRNA United States
- WAL United States
- Employees
- MRNA N/A
- WAL N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- WAL Major Banks
- Sector
- MRNA Health Care
- WAL Finance
- Exchange
- MRNA Nasdaq
- WAL Nasdaq
- Market Cap
- MRNA 10.9B
- WAL 10.1B
- IPO Year
- MRNA 2018
- WAL 2005
- Fundamental
- Price
- MRNA $24.47
- WAL $88.37
- Analyst Decision
- MRNA Hold
- WAL Strong Buy
- Analyst Count
- MRNA 19
- WAL 13
- Target Price
- MRNA $43.50
- WAL $97.62
- AVG Volume (30 Days)
- MRNA 9.9M
- WAL 942.3K
- Earning Date
- MRNA 11-06-2025
- WAL 10-16-2025
- Dividend Yield
- MRNA N/A
- WAL 1.73%
- EPS Growth
- MRNA N/A
- WAL 14.60
- EPS
- MRNA N/A
- WAL 7.61
- Revenue
- MRNA $3,078,000,000.00
- WAL $3,120,700,000.00
- Revenue This Year
- MRNA N/A
- WAL $14.78
- Revenue Next Year
- MRNA $10.17
- WAL $10.40
- P/E Ratio
- MRNA N/A
- WAL $11.58
- Revenue Growth
- MRNA N/A
- WAL 10.46
- 52 Week Low
- MRNA $23.15
- WAL $57.05
- 52 Week High
- MRNA $79.96
- WAL $98.10
- Technical
- Relative Strength Index (RSI)
- MRNA 38.50
- WAL 58.46
- Support Level
- MRNA $23.78
- WAL $87.11
- Resistance Level
- MRNA $25.48
- WAL $93.29
- Average True Range (ATR)
- MRNA 1.09
- WAL 2.18
- MACD
- MRNA 0.05
- WAL 0.14
- Stochastic Oscillator
- MRNA 25.00
- WAL 59.31
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About WAL Western Alliance Bancorporation (DE)
Western Alliance Bancorporation is a Las Vegas-based holding company with regional banks operating in Nevada, Arizona, and California. The bank offers retail banking services and focuses on mortgages for retail customers and commercial loans. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.